Atlas Trials

Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia

Clinical trial NCT04947631 · COMPLETED

Trial details

NCT number
NCT04947631
Sponsor
Dongkook Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Benign Prostatic Hyperplasia
Start date
2021-07-27
Primary completion
2023-06-12
Enrollment
667

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.